Earlier this month, GranatumX, which uses a web-based graphical environment, was approved for the Human Cell Atlas Data Portal's analysis tools registry.
The method, which uses a metabolic marker called hexokinase-2, could be developed to predict cancer patient prognosis and determine progression-free survival.
The University of Washington spinout, formerly called Split Biosciences, has received orders for its new whole-transcriptome kit from 50 early-access partners.
The study uncovered virus-specific as well as shared host factors, including a lysosomal protein that SARS-CoV-2 requires to infect primary lung cells.
SUGAR-seq, a single-cell method developed by researchers in Australia, is a first step towards analyzing differences in glycosylation in various cell types.
The single-cell and spatial genomics company is planning a 50 percent increase in headcount, including the addition of 100 people to its commercial organization.
The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.
